Company: BWNB
Filing Date: 2025-06-10
Form Type: 424B5
Source: 0001104659-25-058204
Chunk: 19

Company: Babcock & Wilcox Enterprises, Inc.
Filing Date: 2025-06-10
Form: 424B5
Chunk 19
---
 conditions.

Sales of the Common Stock,
if any, under this prospectus supplement may be made in transactions that are deemed to be “at the market,” as defined in
Rule 415 under the Securities Act.

The designated Agent will
provide written confirmation of a sale to us no later than the opening of the trading day on the NYSE following each trading day in which
the shares of Common Stock are sold under the Sales Agreement. Each confirmation will include the number of shares of Common Stock sold
on the preceding day, the sales price of the Common Stock sold, the aggregate gross sales proceeds, the net proceeds to us and the compensation
payable by us to the designated Agent in connection with the sales.

The designated Agent will
receive a commission from us equal to 3.0% of the gross sales price of any shares of Common Stock sold through the designated Agent under
the Sales Agreement. We estimate that the total expenses for the offering, excluding compensation payable to the Agents under the terms
of the Sales Agreement, will be approximately $150,000. This estimate includes the reimbursement by the Company of the reasonable fees
and expenses of the Agents in connection with the transactions contemplated by the Sales Agreement. In addition, we have agreed to reimburse
the Agents for (i) the fees and disbursements of their counsel, payable upon execution of the Sales Agreement, in an amount not to exceed
$60,000, (ii) up to $5,000 per calendar quarter, for ongoing diligence arising from the transactions contemplated by the Sales Agreement
and (iii) the fees and disbursements of their counsel, payable in connection with this refiling, in an amount not to exceed $15,000.

Settlement for sales of
our Common Stock will occur on the first trading day following the date on which such sales are made, or on some other date that is
agreed upon by us and the Agents in connection with a particular transaction, in return for payment of the net proceeds to us. There
is no arrangement for funds to be received in an escrow, trust or similar arrangement.

We will report at least quarterly
the number of shares of Common Stock sold through the Agents under the Sales Agreement, the net proceeds to us and the compensation paid
by us to the Agents, if any.

In connection with the sale
of the Common Stock on our behalf, the Agents will be deemed to be “underwriters” within the meaning of the Securities Act,
and the compensation of the Agents will be